Elevated Free Testosterone Evaluation
Yes, a free testosterone of 12.2 µg/dL is elevated above the reference range and requires systematic evaluation to identify the underlying cause, with particular attention to ruling out androgen-secreting tumors, PCOS, medication use, and other endocrinopathies.
Critical First Steps
Before proceeding with extensive workup, verify the assay accuracy and timing of the test 1. Standard automated immunoassays available in most hospital laboratories are often unreliable for measuring testosterone in women, with systematic differences between assays and excessively broad normal ranges 1. The most reliable assays use liquid chromatography-tandem mass spectrometry (LC-MS/MS) or compute free testosterone from total testosterone and SHBG concentrations 1.
Optimal testing conditions require:
- Early morning collection (testosterone varies ~25% around the mean and peaks in early morning) 1
- Follicular phase (days 4-10) in regularly cycling women 1
- Verification that patient is not taking medications affecting SHBG: thyroid hormones, estrogen-containing drugs, or valproic acid 2
Risk Stratification Algorithm
High-Risk Features Requiring Urgent Evaluation
Immediately assess for androgen-secreting neoplasm if any of the following are present 1:
- Sudden onset or rapid progression of symptoms
- Virilization signs (clitoromegaly, increased muscularity, voice deepening)
- Abdominal or pelvic mass
- Progression despite therapy
Systematic Workup Based on Clinical Presentation
1. Medication History First, obtain detailed history of androgenic drug use 1:
- Anabolic or androgenic steroids (particularly in athletes, patients with endometriosis or sexual dysfunction)
- Valproic acid (the only anticonvulsant that raises testosterone) 1
- Danazol
2. Additional Hormone Testing
Measure DHEAS 2:
- DHEAS >600 µg/dL (16,000 nmol/L) indicates androgen-secreting adrenal adenoma → obtain abdominal imaging urgently 2
- Normal DHEAS with elevated testosterone suggests ovarian source (hyperthecosis or ovarian tumor) 2
Measure early morning 17-hydroxyprogesterone if patient is in high-risk ethnic group 1:
- Ashkenazi Jews (prevalence 1 in 27)
- Hispanics (1 in 40)
- Slavics (1 in 50)
- This screens for nonclassic congenital adrenal hyperplasia
3. Assess for PCOS (most common cause of hyperandrogenemia) 1:
- Menstrual irregularity or infertility
- Acne, seborrhea, pattern balding
- Central obesity
- Acanthosis nigricans
4. Screen for Other Endocrinopathies 1:
- Hyperprolactinemia
- Cushing's syndrome
- Acromegaly
- Thyroid dysfunction
Important Caveats
The degree of testosterone elevation poorly predicts the underlying diagnosis 1. Even modest elevations can be associated with androgen-secreting tumors, which may have indolent presentations 1. Approximately 0.2% of hyperandrogenic women have androgen-secreting tumors, with over half being malignant 1.
Free testosterone is more sensitive than total testosterone for detecting androgen excess because hirsute women commonly have relatively low SHBG levels, which increases the free fraction 1. However, there is no uniform laboratory standard for free testosterone levels, and assay-specific results differ widely 1.
Management Approach
If no tumor or serious endocrinopathy is identified and PCOS is suspected, the elevation is typically LH-dependent and can be suppressed with 2:
- GnRH agonists
- Estrogen-progestogen combinations
- Cyproterone acetate
Do not delay imaging if clinical features suggest neoplasm, even with only modest testosterone elevation 1.